Antoine Saliba

34PUBLICATIONS
132CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical molecular engineering of nucleic acids and proteinsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 23, 2026
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents.

|Aug 17, 2026
Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia.

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

|Jun 12, 2026
Menin Inhibition in Acute Myeloid Leukemia: Rewiring Leukemic Transcriptional Networks.

|Jun 09, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

|Jun 02, 2026
Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

Pageof 6

Frequent Collaborators

15 joint publications

Abhishek Mangaonkar

15 joint publications

Aref Al-Kali

14 joint publications

Talha Badar

14 joint publications

Ayalew Tefferi